2024年2期
World Journal of Hepatology
EDITORIAL
- New markers of fibrosis in hepatitis C: A step towards the Holy Grail?
- Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?
- Insights into skullcap herb-induced liver injury
- Non-invasive assessment of esophageal varices: Status of today
- Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients
- Advancements in autoimmune hepatitis management: Perspectives for future guidelines
- Interleukins in liver disease treatment
- Changes in the etiology of liver cirrhosis and the corresponding management strategies
REVIEW
MINIREVIEWS
ORIGINAL ARTICLE
- Predicting major adverse cardiovascular events after orthotopic liver transplantation using a supervised machine learning model: A cohort study
- Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease
- Epidemiological survey of cystic echinococcosis in southwest China: From the Qinghai-Tibet plateau to the area of Yunnan
- Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis
- Evaluation of G3BP1 in the prognosis of acute and acute-on-chronic liver failure after the treatment of artificial liver support system
- Yinhuang granule alleviates carbon tetrachloride-induced liver fibrosis in mice and its mechanism